Publications by: Christine B, Ambrosone
Up a level |
Hoque, Ashraful, Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K.V., vanBokhoven, Adrie, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Ambrosone, Christine B., and Thompson, Ian (2015) Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease. Urology, 85 (3). pp. 616-620.
Tang, Li, Yao, Song, Till, Cathee, Goodman, Phyllis J., Tangen, Catherine M., Wu, Yue, Kristal, Alan R., Platz, Elizabeth A., Neuhouser, Marian L., Stanczyk, Frank Z., Reichardt, Juergen, Santella, Regina M., Hsing, Ann, Hoque, Ashraful, Lippman, Scott M., Thompson, Ian M., and Ambrosone, Christine B, (2011) Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis, 32 (10). pp. 1500-1506.
Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen, Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L,, Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., and Hoque, Ashraful (2011) Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer causes and control, 22 (8). pp. 1121-1131.